Nusinersen

4 trials 1 recruiting MMusculoskeletal Orphan designation

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

3 Completed trials

1 Sponsors

6 Countries

Phase III

Phase IV

Phase I (Other)

Phase III: 2 Phase IV: 1 Phase I (Other): 1

Oversight events:

1 corrective measure across 1 trial

View oversight register →

Sponsors using this IMP

Biogen Idec Research Limited 4

All trials

4 total

A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants… Recruiting

2024-514239-21-00 Phase I (Other) 5 countries Biogen Idec Research Limited
A Study to Evaluate Higher Dose (HD) Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy Previously Treated With Risdiplam (AS… Ended

2023-505639-11-00 Phase III 3 countries Biogen Idec Research Limited
Extension Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy Who Previously Participated in a Study With Nusinersen … Ended

2023-505637-27-00 Phase III 3 countries Biogen Idec Research Limited
A Study of Nusinersen Among Participants With Spinal Muscular Atrophy Who Received Onasemnogene Abeparvovec (RESPOND) Ended

2023-505640-18-00 Phase IV 3 countries Biogen Idec Research Limited

Showing 1–4 of 4 trials

← All drugs A–Z